[Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding Coron]
[China Ceramics Co., Ltd. c/o Jinjiang Hengda Ceramics Co., Ltd. Junbing Industrial Zone, Anhai Jinjiang City, Fujian Province People’s Republic of China June 11, 2020 Division of Corporation Finance Office of Manufacturing 100 F Street, NE Attn: Thomas Jones, Esq. Re: Request for Acceleration China ]
[China Ceramics Co., Ltd. c/o Jinjiang Hengda Ceramics Co., Ltd. Junbing Industrial Zone, Anhai Jinjiang City, Fujian Province People’s Republic of China June 11, 2020 Division of Corporation Finance Office of Manufacturing 100 F Street, NE Attn: Thomas Jones, Esq. Re: Request for Acceleration China ]
[中國海洋石油有限公司 CNOOC LIMITED CNOOC Limited Announces Qinhuangdao 33-1S Oilfield Phase I Project Commences Production (Hong Kong, June 11, 2020) - CNOOC Limited (the “Company”, SEHK: 00883, NYSE: CEO, TSX: CNU) announced today that Qinhuangdao 33-1S oilfield phase I project has commenced production. Qinh]
[中國海洋石油有限公司 CNOOC LIMITED CNOOC Limited Announces Qinhuangdao 33-1S Oilfield Phase I Project Commences Production (Hong Kong, June 11, 2020) - CNOOC Limited (the “Company”, SEHK: 00883, NYSE: CEO, TSX: CNU) announced today that Qinhuangdao 33-1S oilfield phase I project has commenced production. Qinh]
[CALCULATION OF REGISTRATION FEE Title of each class of securities Amount to be Proposed Proposed Amount of Class A ordinary shares, par value US$0.00002 per share(4) 152,950,000 US$29.16 US$4,460,022,000 US$578,910.86 (1) (2) Calculated based on an exchange rate of HK$7.7499 to US$1.00 as of June 5,]
[CALCULATION OF REGISTRATION FEE Title of each class of securities Amount to be Proposed Proposed Amount of Class A ordinary shares, par value US$0.00002 per share(4) 152,950,000 US$29.16 US$4,460,022,000 US$578,910.86 (1) (2) Calculated based on an exchange rate of HK$7.7499 to US$1.00 as of June 5,]
[PART I 3 Item 1. Identity of Directors, Senior Management and Advisers 3 Item 2. Offer Statistics and Expected Timetable 3 Item 3. Key Information 3 Item 4. Information on the Company 23 Item 4A. Unresolved Staff Comments 45 Item 5. Operating and Financial Review and Prospects 45 Item 6. Directors, ]
